Toripalimab

Toripalimab · Shanghai Junshi Biosciences Co., Ltd.

Drug timelines are a Plus or Pro feature.

310 regulatory and trial events tracked for Toripalimab, covering 2019-01-23 to 2026-07-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC [Phase 3]